LILY34:BVMF
Eli Lilly And Company BDR
196,79 BRL
0,00%
(0,00) 1 d.
9. 10., 17:06:00 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre LILY34…
Otvoriť
195,67 BRL
Vysoká
196,79 BRL
Nízka
191,80 BRL
Trh. kap.
1,11 bil.
Priem. obj.
36,60 tis.
Objem
41,76 tis.
Max. za 52 týž.
223,07 BRL
Min. za 52 týž.
141,56 BRL
Akcie v obehu
941,36 mil.
Počet zamestnancov
50 tis.
Otvoriť
195,67 BRL
Vysoká
196,79 BRL
Nízka
191,80 BRL
Trh. kap.
1,11 bil.
Priem. obj.
36,60 tis.
Objem
41,76 tis.
Max. za 52 týž.
223,07 BRL
Min. za 52 týž.
141,56 BRL
Akcie v obehu
941,36 mil.
Počet zamestnancov
50 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
TipRanks
·
pred 9 hodinami
Eli Lilly (LLY) Stock: Why Taking Profits Could Make Sense Ahead of 2027
Investing.com Nigeria
·
pred 18 hodinami
Form 144 ELI LILLY AND COMPANY For: 11 October By Investing.com
Insider Monkey
·
pred 1 dňom
Eli Lilly (LLY) Posted 48% Revenue Growth. Why Does the Stock Trade Below Its Average Multiple?
24/7 Wall St.
·
pred 2 dňami
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Informácie o subjekte Eli Lilly And Company BDR
Generálny riaditeľDavid A. Ricks
Zamestnanci50 tis.
Dátum založenia1876
Hlavné sídloIndianapolis, Indiana, Spojené štáty americké
Odvetvie-
Weblilly.com